Terremoto Biosciences

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$175M

Terremoto Biosciences is a biotechnology company that has raised $175 million in a Series B financing round to advance its platform and support the development of multiple in-house programs targeting diseases of high unmet medical need.

Total Funding

$250M

Headquarters

South San Francisco, USA

Founded

N/A

Website

terremotobio.com

Focus Areas

Biotechnology

Disease Targeting

Drug Discovery

Drug Development

High Unmet Medical Need

Platform Advancement

Investors